Does progress in ‘omics’ help in human health risk assessment?

13 October 2017 09:00-17:00, London, United Kingdom

Advances in metabolomics, proteomics and genomics caused great excitement in anticipation for their potential use in toxicological investigations and risk assessments.  Toxicologists were some of the first to demonstrate the utility of the novel analytical and DNA analysis techniques in experimental health sciences. More than a decade on how or have these technologies helped us towards more secure risks assessments?

The meeting will include the presentation of the 2017 RSC Toxicology Award to Professor Andy Smith, MRC Toxicology Unit.

Early bird rates - £90 RSC / £120 non-members. Special rate available for IGHRC members.

Confirmed speakers:
Andy Smith, MRC Toxicology UnitThe changing ‘omics’ landscape
Tim Gant, Public Health EnglandToxicogenomics, human risk assessment and possible regulatory uses
Muireann Coen, Imperial College London / AstraZenecaHuman early life exposome (HELIX) and omics
Andy White, SETAC, Unilever Application and use of ‘omic’ data for next generation risk assessment
Mark Viant, Phenome Centre, University of BirminghamAccelerating the impacts of metabolomics in regulatory toxicology
George Loizou, HSE’s Health & Safety LaboratoryMetabolomics in regulatory toxicology?
Marion MacFarlane, MRC Toxicology Unit Are long carbon nanotubes the new asbestos; genomic evidence?
The Royal Society of Chemistry

The Royal Society of Chemistry, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry